SlideShare a Scribd company logo
IDENTIFICATION OF NOVELANTICANCER COMPOUND
AGAINST ZINC FINGER PROTEIN (BTB): DOCKING STUDIES
Undertaken Supervision of
Sanjay Kumar
Programmer, Bioinformatics Center, Biotech Park, Lucknow
Presented by:
Mudit Kumar Srivastava
M.Sc Bioinformatics
Roll no:9Central University Of South Bihar 1
 Cancer is a group of diseases characterized by the uncontrolled growth and spread
of abnormal cells.
 Generally cancer cells develop from normal cells due to damage of DNA. DNA
damaged might be inherited from the parents, which accounts for inherited cancers
Or by certain environmental exposures such as Smoke, chemical radiation,
infection, obesity, and also from tobacco.
 From the literature review Cancer is the leading cause of death in the world,Half of
men and one third of women in the United States will develop cancer during their
lifetime.
Types of cancer:
There are more than 120 types of cancer some are most recently viewed:
Bladder cancer Liver cancer Leukemia cancer
Brain cancer Lung cancer Thyroid cancer
Breast cancer Prostrate cancer Ovarian cancer
Cervical cancer Oral cancer Pancreatic cancer
Kidney cancer Skin cancer Uterine cancer
CANCER: A BIG PROBLEM
Central University Of South Bihar 2
Central University Of South Bihar 3
Central University Of South Bihar 4
Aimed to determine the activity of an anti-cancerous compound
which may works as effective anti-cancer drug for the cure of
cancer diseases.
OBJECTIVE
Central University Of South Bihar 5
 ZBTB7A called as Pokémon stands for "POK erythroid myeloid ontogenic factor"
is a gene that may act as a master switch for cancer and is responsible for the
proliferation of cancer through out surrounding cells.
 ZBTB7A which is a cancer causing gene, it expressed in all proliferating cells highly
in malignant tissues than in the corresponding benign or normal tissue (breast,
lung, prostate).
 Zinc finger and BTB domain-containing protein 7A is a protein that in humans is
encoded by the ZBTB7A and composed of 584 amino acids (a.a).
 A zinc finger is a small protein structural motif that is characterized by
the coordination of one or more zinc ions in order to stabilize the fold.
 The BTB (Born to bind) or POZ domain is a protein-protein interaction motif that
is found throughout eukaryotes.
 It belongs to the POK family of transcriptional repressors.
TARGET GENE & PROTEIN
Central University Of South Bihar 6
 In human it was proved that, it is an important molecular switch to an oncogenesis
but little is known about the regulation of this gene expression.
 The mechanisms of Zbtb7A gene expression regulation is of importance for
understanding the precise roles of Zbtb7A in physiological and pathological
processes.
 Zbtb7A is also a repressor of the ARF tumor suppressor gene and it expressed at
high level.
 There are only 21 articles specifically referring this gene in pubmed which is very
less.
 So, Functionally this gene has been tested and reported as a association to a disease
of cancer (Breast,lung,Prostrate).
WHY ZBTB7A?
Central University Of South Bihar 7
Protein:
PDB ID: 2NN2 Organism: Homo sapiens Length: 584 a.a
Molecule: Zinc finger and BTB domain-containing protein 7A
Gene name: ZBTB7A Chain: A,B
Ligand Search:
 Total 80 anti cancer compounds that have anti cancerous properties, were retrieved
from literature and there 3D structure and other properties were downloaded from a
from the Pubchem database.
MATERIALS
Central University Of South Bihar 8
Databases:
Uniprot www.uniprot.org
Ncbi www.ncbi.nlm.nih.gov
Pdb www.rcsb.org
Pubchem https://pubchem.ncbi.nlm.nih.gov
Tools and Software's:
Openbabel v2.3.1
AutoDock v4.2
Cygwin Terminal
Chimera v1.10.1
PyMol v0.99
Central University Of South Bihar 9
METHOD AS A FLOW CHART
Central University Of South Bihar 10
Target Receptor
 The BTB domain sequences of Zinc finger protein were downloaded from the
uniprot database for the blast to find the structure.
 The blast result of the domain shows the 100% query and identity with the (Pdb id:
2NN2), so there was no needed to model the structure and hence it uses as the target
receptor for Docking.
Blast result of target protein
.
RESULT & DISCUSSION
Central University Of South Bihar 11
Ligand
 By applying Lipinski rule of five we get only 54 compounds out of 80 for docking.
 From the 54 Docked compounds the top ten compounds, having minimum binding
energy were selected.

Table: Top ten Docked compounds
Central University Of South Bihar 12
Interaction Result
 By adding the atom of the ligand from .dlg file into the protein .pdb file the
interacted ligand binding site can be seen.
 The interaction analysis of protein and ligand complex have been done with the
help of “LIGPLOT” which is an automatically generated schematic diagram tool of
protein-ligand PDB file.
Table: Top Ten Compounds with there Hydrogen Bonds and Hydrophobic Interaction
Central University Of South Bihar
13
 The top ten interacted compounds having no of hydrogen bonds and hydrophobic
interaction.
 Among these top ten compounds, those having the maximum no. of hydrogen bond
and lowest binding energy, we selected it as a best anti cancerous compound.
Fig: Target protein (2NN2) binding with the ligand view generated by Ligplot
Central University Of South Bihar 14
CONCLUSION
 The Zinc finger and BTB domain-containing protein7 2NN2 selected as the target
protein receptor which docked with 54 anti cancer compounds.
 The protein-ligand complex with the lowest binding energy, hydrogen bonds and
may be considered as best drug candidate and may use for the treatment of
cancerous diseases after experimental validation.
 We select Cyproterone (id 5284537) pose6, having the binding energy -5.36 and the
no. of hydrogen bond binding is 2 which are maximum among the top ten pose,
which may work as effective anti-cancer drug for the cure of cancerous diseases.
Central University Of South Bihar 15
 I am grateful to my guide Mr. Sanjay Kumar, Programmer, Bioinformatics Center,
Biotech Park, Lucknow, for his generous consideration and kindness toward this
Project.
 Thankful to my college Central University of South Bihar and Professors,
Bioinformatics Center to permit me the permission to work on this project .
ACKNOWLEDGMENT
Central University Of South Bihar 16
Central University Of South Bihar 17

More Related Content

What's hot

Manejo oncológico del cáncer de pulmón
Manejo oncológico del cáncer de pulmónManejo oncológico del cáncer de pulmón
Manejo oncológico del cáncer de pulmón
jalmenarez
 
Mi rna series i-dec 2012
Mi rna series i-dec 2012Mi rna series i-dec 2012
Mi rna series i-dec 2012
Elsa von Licy
 
In Silico Prescription of Anticancer Drugs Reveals Targeting Opportunities
In Silico Prescription of Anticancer Drugs Reveals Targeting OpportunitiesIn Silico Prescription of Anticancer Drugs Reveals Targeting Opportunities
In Silico Prescription of Anticancer Drugs Reveals Targeting Opportunities
Nuria Lopez-Bigas
 
Introduction cancer genetics and genomics
Introduction cancer genetics and genomicsIntroduction cancer genetics and genomics
Introduction cancer genetics and genomics
Nuria Lopez-Bigas
 
Chromatin regulation 2013
Chromatin regulation 2013Chromatin regulation 2013
Chromatin regulation 2013
Elsa von Licy
 

What's hot (20)

PhD midterm report
PhD midterm reportPhD midterm report
PhD midterm report
 
Talk on Cancer awareness on World cancer day-at JCI Talcher meet
Talk on Cancer awareness on World cancer day-at JCI Talcher meetTalk on Cancer awareness on World cancer day-at JCI Talcher meet
Talk on Cancer awareness on World cancer day-at JCI Talcher meet
 
Van criekinge next_generation_epigenetic_profling_vlille
Van criekinge next_generation_epigenetic_profling_vlilleVan criekinge next_generation_epigenetic_profling_vlille
Van criekinge next_generation_epigenetic_profling_vlille
 
Manejo oncológico del cáncer de pulmón
Manejo oncológico del cáncer de pulmónManejo oncológico del cáncer de pulmón
Manejo oncológico del cáncer de pulmón
 
Mi rna series i-dec 2012
Mi rna series i-dec 2012Mi rna series i-dec 2012
Mi rna series i-dec 2012
 
In Silico Prescription of Anticancer Drugs Reveals Targeting Opportunities
In Silico Prescription of Anticancer Drugs Reveals Targeting OpportunitiesIn Silico Prescription of Anticancer Drugs Reveals Targeting Opportunities
In Silico Prescription of Anticancer Drugs Reveals Targeting Opportunities
 
Introduction cancer genetics and genomics
Introduction cancer genetics and genomicsIntroduction cancer genetics and genomics
Introduction cancer genetics and genomics
 
2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented
 
High-Throughput Sequencing
High-Throughput SequencingHigh-Throughput Sequencing
High-Throughput Sequencing
 
Oncogenes
OncogenesOncogenes
Oncogenes
 
Bioinformatics as a tool for understanding clinically significant variations ...
Bioinformatics as a tool for understanding clinically significant variations ...Bioinformatics as a tool for understanding clinically significant variations ...
Bioinformatics as a tool for understanding clinically significant variations ...
 
The role of DNA methylation in complex diseases
The role of DNA methylation in complex diseasesThe role of DNA methylation in complex diseases
The role of DNA methylation in complex diseases
 
Oncogene activation
Oncogene  activationOncogene  activation
Oncogene activation
 
I International Symposium: Neurobiology and Biomarkers of Brain Aging - Micro...
I International Symposium: Neurobiology and Biomarkers of Brain Aging - Micro...I International Symposium: Neurobiology and Biomarkers of Brain Aging - Micro...
I International Symposium: Neurobiology and Biomarkers of Brain Aging - Micro...
 
Ibica2014 p(8) visualizing and identifying the dna methylation
Ibica2014 p(8) visualizing and identifying the dna methylationIbica2014 p(8) visualizing and identifying the dna methylation
Ibica2014 p(8) visualizing and identifying the dna methylation
 
Neoplasia 4
Neoplasia 4Neoplasia 4
Neoplasia 4
 
Biomed central
Biomed centralBiomed central
Biomed central
 
Webinar about JASPAR BioPython module and MANTA.
Webinar about JASPAR BioPython module and MANTA.Webinar about JASPAR BioPython module and MANTA.
Webinar about JASPAR BioPython module and MANTA.
 
Chromatin regulation 2013
Chromatin regulation 2013Chromatin regulation 2013
Chromatin regulation 2013
 
Computational models for the analysis of gene expression regulation and its a...
Computational models for the analysis of gene expression regulation and its a...Computational models for the analysis of gene expression regulation and its a...
Computational models for the analysis of gene expression regulation and its a...
 

Viewers also liked (6)

Docking studies
Docking studiesDocking studies
Docking studies
 
molecular docking
molecular dockingmolecular docking
molecular docking
 
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS
 
docking
docking docking
docking
 
Computer Aided Drug Design ppt
Computer Aided Drug Design pptComputer Aided Drug Design ppt
Computer Aided Drug Design ppt
 
Molecular docking and_virtual_screening
Molecular docking and_virtual_screeningMolecular docking and_virtual_screening
Molecular docking and_virtual_screening
 

Similar to Docking studies

Eradicating diseases (genome)
Eradicating diseases (genome)Eradicating diseases (genome)
Eradicating diseases (genome)
Utkarsh Verma
 
Bakalářka Jana - odevzdaná verze
Bakalářka Jana - odevzdaná  verzeBakalářka Jana - odevzdaná  verze
Bakalářka Jana - odevzdaná verze
Milos Beran
 
QMB_Poster_Tom_Kelly
QMB_Poster_Tom_KellyQMB_Poster_Tom_Kelly
QMB_Poster_Tom_Kelly
Tom Kelly
 
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCCCapacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Mauricio Lema
 
Clin cancer res 2005-barth-3987-4002
Clin cancer res 2005-barth-3987-4002Clin cancer res 2005-barth-3987-4002
Clin cancer res 2005-barth-3987-4002
Juan J. Rodríguez B.
 
Geveart Lab SIMR Paper
Geveart Lab SIMR PaperGeveart Lab SIMR Paper
Geveart Lab SIMR Paper
Nathan Dalal
 

Similar to Docking studies (20)

Eradicating diseases (genome)
Eradicating diseases (genome)Eradicating diseases (genome)
Eradicating diseases (genome)
 
Pre-clinical drug prioritization via prognosis-guided genetic interaction net...
Pre-clinical drug prioritization via prognosis-guided genetic interaction net...Pre-clinical drug prioritization via prognosis-guided genetic interaction net...
Pre-clinical drug prioritization via prognosis-guided genetic interaction net...
 
Bakalářka Jana - odevzdaná verze
Bakalářka Jana - odevzdaná  verzeBakalářka Jana - odevzdaná  verze
Bakalářka Jana - odevzdaná verze
 
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
 
Friend EORTC 2012-11-08
Friend EORTC 2012-11-08Friend EORTC 2012-11-08
Friend EORTC 2012-11-08
 
Rational_Drug_Design.ppt
Rational_Drug_Design.pptRational_Drug_Design.ppt
Rational_Drug_Design.ppt
 
Analysis of Parasporin (Anti-cancer) proteins of Bacillus thuringiensis.pdf
Analysis of Parasporin (Anti-cancer) proteins of Bacillus thuringiensis.pdfAnalysis of Parasporin (Anti-cancer) proteins of Bacillus thuringiensis.pdf
Analysis of Parasporin (Anti-cancer) proteins of Bacillus thuringiensis.pdf
 
QMB_Poster_Tom_Kelly
QMB_Poster_Tom_KellyQMB_Poster_Tom_Kelly
QMB_Poster_Tom_Kelly
 
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCCCapacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
 
5000 Arijit_June 2015.pptx
5000 Arijit_June 2015.pptx5000 Arijit_June 2015.pptx
5000 Arijit_June 2015.pptx
 
Clin cancer res 2005-barth-3987-4002
Clin cancer res 2005-barth-3987-4002Clin cancer res 2005-barth-3987-4002
Clin cancer res 2005-barth-3987-4002
 
Nano-DIM.ppt
Nano-DIM.pptNano-DIM.ppt
Nano-DIM.ppt
 
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
Geveart Lab SIMR Paper
Geveart Lab SIMR PaperGeveart Lab SIMR Paper
Geveart Lab SIMR Paper
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
Drug discovery and development. Introducing
Drug discovery and development. IntroducingDrug discovery and development. Introducing
Drug discovery and development. Introducing
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
New stratigies for_combating_cancer
New stratigies for_combating_cancerNew stratigies for_combating_cancer
New stratigies for_combating_cancer
 
Drug Discovery Today: Fighting TB with Technology
Drug Discovery Today: Fighting TB with TechnologyDrug Discovery Today: Fighting TB with Technology
Drug Discovery Today: Fighting TB with Technology
 

Recently uploaded

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Accounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdfAccounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdf
YibeltalNibretu
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
Avinash Rai
 

Recently uploaded (20)

MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Accounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdfAccounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdf
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdfINU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
INU_CAPSTONEDESIGN_비밀번호486_업로드용 발표자료.pdf
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
 
Benefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational ResourcesBenefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational Resources
 
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptxMatatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptxJose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 

Docking studies

  • 1. IDENTIFICATION OF NOVELANTICANCER COMPOUND AGAINST ZINC FINGER PROTEIN (BTB): DOCKING STUDIES Undertaken Supervision of Sanjay Kumar Programmer, Bioinformatics Center, Biotech Park, Lucknow Presented by: Mudit Kumar Srivastava M.Sc Bioinformatics Roll no:9Central University Of South Bihar 1
  • 2.  Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells.  Generally cancer cells develop from normal cells due to damage of DNA. DNA damaged might be inherited from the parents, which accounts for inherited cancers Or by certain environmental exposures such as Smoke, chemical radiation, infection, obesity, and also from tobacco.  From the literature review Cancer is the leading cause of death in the world,Half of men and one third of women in the United States will develop cancer during their lifetime. Types of cancer: There are more than 120 types of cancer some are most recently viewed: Bladder cancer Liver cancer Leukemia cancer Brain cancer Lung cancer Thyroid cancer Breast cancer Prostrate cancer Ovarian cancer Cervical cancer Oral cancer Pancreatic cancer Kidney cancer Skin cancer Uterine cancer CANCER: A BIG PROBLEM Central University Of South Bihar 2
  • 3. Central University Of South Bihar 3
  • 4. Central University Of South Bihar 4
  • 5. Aimed to determine the activity of an anti-cancerous compound which may works as effective anti-cancer drug for the cure of cancer diseases. OBJECTIVE Central University Of South Bihar 5
  • 6.  ZBTB7A called as Pokémon stands for "POK erythroid myeloid ontogenic factor" is a gene that may act as a master switch for cancer and is responsible for the proliferation of cancer through out surrounding cells.  ZBTB7A which is a cancer causing gene, it expressed in all proliferating cells highly in malignant tissues than in the corresponding benign or normal tissue (breast, lung, prostate).  Zinc finger and BTB domain-containing protein 7A is a protein that in humans is encoded by the ZBTB7A and composed of 584 amino acids (a.a).  A zinc finger is a small protein structural motif that is characterized by the coordination of one or more zinc ions in order to stabilize the fold.  The BTB (Born to bind) or POZ domain is a protein-protein interaction motif that is found throughout eukaryotes.  It belongs to the POK family of transcriptional repressors. TARGET GENE & PROTEIN Central University Of South Bihar 6
  • 7.  In human it was proved that, it is an important molecular switch to an oncogenesis but little is known about the regulation of this gene expression.  The mechanisms of Zbtb7A gene expression regulation is of importance for understanding the precise roles of Zbtb7A in physiological and pathological processes.  Zbtb7A is also a repressor of the ARF tumor suppressor gene and it expressed at high level.  There are only 21 articles specifically referring this gene in pubmed which is very less.  So, Functionally this gene has been tested and reported as a association to a disease of cancer (Breast,lung,Prostrate). WHY ZBTB7A? Central University Of South Bihar 7
  • 8. Protein: PDB ID: 2NN2 Organism: Homo sapiens Length: 584 a.a Molecule: Zinc finger and BTB domain-containing protein 7A Gene name: ZBTB7A Chain: A,B Ligand Search:  Total 80 anti cancer compounds that have anti cancerous properties, were retrieved from literature and there 3D structure and other properties were downloaded from a from the Pubchem database. MATERIALS Central University Of South Bihar 8
  • 9. Databases: Uniprot www.uniprot.org Ncbi www.ncbi.nlm.nih.gov Pdb www.rcsb.org Pubchem https://pubchem.ncbi.nlm.nih.gov Tools and Software's: Openbabel v2.3.1 AutoDock v4.2 Cygwin Terminal Chimera v1.10.1 PyMol v0.99 Central University Of South Bihar 9
  • 10. METHOD AS A FLOW CHART Central University Of South Bihar 10
  • 11. Target Receptor  The BTB domain sequences of Zinc finger protein were downloaded from the uniprot database for the blast to find the structure.  The blast result of the domain shows the 100% query and identity with the (Pdb id: 2NN2), so there was no needed to model the structure and hence it uses as the target receptor for Docking. Blast result of target protein . RESULT & DISCUSSION Central University Of South Bihar 11
  • 12. Ligand  By applying Lipinski rule of five we get only 54 compounds out of 80 for docking.  From the 54 Docked compounds the top ten compounds, having minimum binding energy were selected.  Table: Top ten Docked compounds Central University Of South Bihar 12
  • 13. Interaction Result  By adding the atom of the ligand from .dlg file into the protein .pdb file the interacted ligand binding site can be seen.  The interaction analysis of protein and ligand complex have been done with the help of “LIGPLOT” which is an automatically generated schematic diagram tool of protein-ligand PDB file. Table: Top Ten Compounds with there Hydrogen Bonds and Hydrophobic Interaction Central University Of South Bihar 13
  • 14.  The top ten interacted compounds having no of hydrogen bonds and hydrophobic interaction.  Among these top ten compounds, those having the maximum no. of hydrogen bond and lowest binding energy, we selected it as a best anti cancerous compound. Fig: Target protein (2NN2) binding with the ligand view generated by Ligplot Central University Of South Bihar 14
  • 15. CONCLUSION  The Zinc finger and BTB domain-containing protein7 2NN2 selected as the target protein receptor which docked with 54 anti cancer compounds.  The protein-ligand complex with the lowest binding energy, hydrogen bonds and may be considered as best drug candidate and may use for the treatment of cancerous diseases after experimental validation.  We select Cyproterone (id 5284537) pose6, having the binding energy -5.36 and the no. of hydrogen bond binding is 2 which are maximum among the top ten pose, which may work as effective anti-cancer drug for the cure of cancerous diseases. Central University Of South Bihar 15
  • 16.  I am grateful to my guide Mr. Sanjay Kumar, Programmer, Bioinformatics Center, Biotech Park, Lucknow, for his generous consideration and kindness toward this Project.  Thankful to my college Central University of South Bihar and Professors, Bioinformatics Center to permit me the permission to work on this project . ACKNOWLEDGMENT Central University Of South Bihar 16
  • 17. Central University Of South Bihar 17